Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy?
Basu, Sandip
Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy? [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov 2013 - 2018-9 p. digital
Publication Type: Letter; Comment
1535-5667
10.2967/jnumed.113.127829 doi
Humans
International Agencies
Molecular Targeted Therapy--methods
Neuroendocrine Tumors--radiotherapy
Nuclear Energy
Radiotherapy--methods
Receptors, Peptide--metabolism
Societies, Scientific
Should grade of tracer uptake on somatostatin receptor-targeted imaging be the major determinant and break the barrier of histopathologic criteria for determining the suitability of Peptide receptor radionuclide therapy? [electronic resource] - Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov 2013 - 2018-9 p. digital
Publication Type: Letter; Comment
1535-5667
10.2967/jnumed.113.127829 doi
Humans
International Agencies
Molecular Targeted Therapy--methods
Neuroendocrine Tumors--radiotherapy
Nuclear Energy
Radiotherapy--methods
Receptors, Peptide--metabolism
Societies, Scientific